BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3081832)

  • 1. AB variant GM2 gangliosidosis: cerebrospinal fluid and neuropathologic characteristics.
    Kotagal S; Wenger DA; Alcala H; Gomez C; Horenstein S
    Neurology; 1986 Mar; 36(3):438-40. PubMed ID: 3081832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of ganglioside Gm2 in cerebrospinal fluid of a patient with the variant AB of infantile Gm2 gangliosidosis.
    Pullarkat RK; Reha H; Beratis NG
    Pediatrics; 1981 Jul; 68(1):106-8. PubMed ID: 7243492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
    Conzelmann E; Sandhoff K
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sandhoff disease: ganglioside G(M2) and asialo-G(M2) accumulation in the cerebrospinal fluid.
    Bernheimer H; Molzer B; Deisenhammer E
    J Neurochem; 1977 Aug; 29(2):351-3. PubMed ID: 407331
    [No Abstract]   [Full Text] [Related]  

  • 5. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J; Binns HJ
    Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM2-gangliosidosis, AB variant: clinico-pathological study of a case.
    de Baecque CM; Suzuki K; Rapin I; Johnson AB; Whethers DL
    Acta Neuropathol; 1975 Dec; 33(3):207-26. PubMed ID: 174379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM2 gangliosidosis in a Japanese spaniel.
    Cummings JF; Wood PA; Walkley SU; de Lahunta A; DeForest ME
    Acta Neuropathol; 1985; 67(3-4):247-53. PubMed ID: 2931941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biochemical abnormalities in porcine GM2-gangliosidosis.
    Kosanke SD; Pierce KR; Bay WW
    Vet Pathol; 1978 Nov; 15(6):685-99. PubMed ID: 108843
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory diagnosis of canine GM2-gangliosidosis using blood and cerebrospinal fluid.
    Yamato O; Satoh H; Matsuki N; Ono K; Yamasaki M; Maede Y
    J Vet Diagn Invest; 2004 Jan; 16(1):39-44. PubMed ID: 14974845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis.
    Erzberger A; Conzelmann E; Sandhoff K
    Clin Chim Acta; 1980 Dec; 108(3):361-8. PubMed ID: 6781795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.
    Hechtman P; Gordon BA; Ng Ying Kin NM
    Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
    Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
    Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification, biochemical and immunological characterisation of hexosaminidase A from variant AB of infantile GM2 gangliosidosis.
    Conzelmann E; Sandhoff K; Nehrkorn H; Geiger B; Arnon R
    Eur J Biochem; 1978 Mar; 84(1):27-33. PubMed ID: 25769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisera against ganglioside GM2: immunochemical and immunohistological studies.
    Schwerer B; Lassmann H; Bernheimer H
    Neuropathol Appl Neurobiol; 1982; 8(3):217-26. PubMed ID: 6214725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult (chronic) GM2 gangliosidosis. Atypical spinocerebellar degeneration in a Jewish sibship.
    Rapin I; Suzuki K; Suzuki K; Valsamis MP
    Arch Neurol; 1976 Feb; 33(2):120-30. PubMed ID: 175770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity.
    Kytzia HJ; Hinrichs U; Maire I; Suzuki K; Sandhoff K
    EMBO J; 1983; 2(7):1201-5. PubMed ID: 6226523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurophysiological investigations in GM1 and GM2 gangliosidoses.
    Pampiglione G; Harden A
    Neuropediatrics; 1984 Sep; 15 Suppl():74-84. PubMed ID: 6100798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
    O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
    Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate specificity of hexosaminidase A isolated from the liver of a patient with a rare form (AB variant) of infantile GM2 gangliosidosis and control tissues.
    Sandhoff K; Conzelmann E; Nehrkorn H
    Adv Exp Med Biol; 1978; 101():727-30. PubMed ID: 96668
    [No Abstract]   [Full Text] [Related]  

  • 20. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
    Harzer K
    Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.